Nucleotides

Nucleotides are the monomeric units — the individual building blocks — that link together to form the long polymer chains of DNA and RNA ^[1]. Every strand of DNA in the human body, and every fragment of PDRN used in skincare and regenerative medicine, is composed of nucleotides arranged in a specific sequence. Understanding what nucleotides are, how they function, and how cells obtain them is fundamental to understanding why PDRN works as a regenerative agent.

Definition and Structure

A nucleotide is a molecular unit consisting of three covalently linked components ^[1]:

1. Nitrogenous Base

The base is the information-carrying component of the nucleotide. There are five nitrogenous bases found in nucleic acids, divided into two chemical families:

• Purines (double-ring structures): Adenine (A) and Guanine (G)
• Pyrimidines (single-ring structures): Cytosine (C), Thymine (T) (found only in DNA), and Uracil (U) (found only in RNA)

In DNA — and therefore in PDRN — the four bases are adenine, guanine, cytosine, and thymine. It is the sequence of these bases along the DNA strand that encodes genetic information and, when PDRN fragments are broken down, determines which specific nucleotide building blocks become available to cells.

2. Pentose Sugar

The sugar component is a five-carbon ring structure. In DNA (and PDRN), this is deoxyribose — distinguished from ribose (found in RNA) by the absence of an oxygen atom at the 2' carbon position ^[1]. This seemingly small chemical difference makes deoxyribose-containing nucleotides more chemically stable, which is why DNA serves as the long-term information storage molecule and why PDRN fragments maintain structural integrity during processing and formulation.

3. Phosphate Group

One or more phosphate groups are attached to the 5' carbon of the sugar. In a nucleotide triphosphate (such as ATP, the cell's energy currency), three phosphate groups are linked in a chain. The bonds between these phosphate groups store significant chemical energy. When nucleotides are incorporated into a growing DNA strand, two phosphate groups are cleaved off, and the resulting nucleotide monophosphate is linked to the chain via a phosphodiester bond ^[1].

Nucleotides vs. Nucleosides

A common point of confusion is the distinction between nucleotides and nucleosides. A nucleoside is simply a base attached to a sugar — without the phosphate group. A nucleotide is a nucleoside with one or more phosphate groups attached ^[1]. This distinction matters for PDRN because when PDRN fragments are degraded by extracellular nucleases, both nucleosides and free bases are released, and both can enter the nucleotide salvage pathway through different enzymatic routes ^[3][4].

The four deoxyribonucleosides relevant to PDRN are:

• Deoxyadenosine (adenine + deoxyribose)
• Deoxyguanosine (guanine + deoxyribose)
• Deoxycytidine (cytosine + deoxyribose)
• Thymidine (thymine + deoxyribose)

How Nucleotides Form DNA

Nucleotides polymerize — link together in sequence — through phosphodiester bonds that connect the 5' phosphate of one nucleotide to the 3' hydroxyl of the next ^[1]. This creates the sugar-phosphate backbone of DNA, with the bases projecting inward. Two complementary strands pair through hydrogen bonds between bases (A pairs with T; G pairs with C) to form the iconic double helix structure described by Watson and Crick in 1953.

A single human cell contains approximately 6.4 billion nucleotide pairs in its genome. Each time a cell divides, it must synthesize 6.4 billion new nucleotides to replicate its DNA — an enormous metabolic demand that explains why cells maintain both de novo synthesis and salvage pathways to ensure adequate nucleotide supply ^[1][3].

Relevance to PDRN

PDRN (polydeoxyribonucleotide) is, by definition, a polymer of deoxyribonucleotides — a chain of nucleotide units linked by phosphodiester bonds, derived from the DNA of Oncorhynchus keta (chum salmon) ^[2]. The molecular weight of PDRN fragments ranges from 50 to 1,500 kDa, corresponding to chains of roughly 150 to 4,500 nucleotide pairs.

When PDRN is administered to tissue, either by injection (as in Rejuran Healer) or topical application (as in PDRN serums), the polymer chains undergo progressive enzymatic degradation ^[2][5]:

1. Endonucleases cleave the PDRN chains at internal sites, producing shorter oligonucleotide fragments.
2. Exonucleases trim these fragments from the ends, releasing individual nucleotides and nucleosides.
3. Phosphatases remove phosphate groups from nucleotides, yielding free nucleosides.
4. Nucleosidases can further cleave nucleosides into free bases and deoxyribose sugar.

Each of these degradation products has biological utility. The nucleosides and free bases enter cells through membrane transporters and feed directly into the nucleotide salvage pathway, where salvage enzymes (thymidine kinase, HGPRT, APRT) convert them back into active nucleotide triphosphates that DNA polymerase can use for replication and repair ^[2][3].

Critically, the adenosine released during PDRN degradation also binds to adenosine A2A receptors on the cell surface, activating the cAMP-PKA-CREB signaling cascade. This dual mechanism — receptor-mediated signaling plus metabolic substrate supply — is what distinguishes PDRN from single-mechanism regenerative ingredients ^[2][5].

The Salvage Pathway Connection

Cells obtain nucleotides through two metabolic routes ^[3][4]:

• De novo synthesis builds nucleotides from scratch using amino acids, CO2, and cofactors. This is energy-intensive, requiring 6-10 enzymatic steps per nucleotide.
• The salvage pathway recycles pre-formed bases and nucleosides back into active nucleotides in just 1-2 enzymatic steps.

The salvage pathway typically handles 80-90% of nucleotide production in resting cells ^[4]. However, when cells are actively dividing — as they are during wound healing, post-procedure recovery, or PDRN-stimulated regeneration — the demand for nucleotides can outstrip what salvage of endogenous recycled materials alone can provide.

This is where PDRN provides a decisive advantage: it floods the local tissue environment with an exogenous supply of salvageable nucleotide building blocks. Fibroblasts stimulated to proliferate and synthesize collagen, keratinocytes turning over in the epidermis, and endothelial cells forming new capillaries all have immediate access to the nucleotide substrates they need without waiting for energy-expensive de novo synthesis ^[2][3].

Clinical Significance

The nucleotide composition of PDRN has several clinically relevant implications:

Wound Healing Acceleration

In tissues with active wound healing, local nucleotide pools can become depleted as cells rapidly divide and synthesize new DNA. PDRN-derived nucleotides replenish these pools, removing a metabolic bottleneck and allowing cell proliferation to proceed at its maximum signaling-limited rate rather than its substrate-limited rate ^[2].

Synergy with Procedural Treatments

When PDRN is used after fractional lasers, microneedling, or chemical peels, the controlled injury triggers a burst of cell proliferation for repair. PDRN-derived nucleotides ensure these rapidly dividing cells have the raw materials for DNA replication, which is why combination protocols often produce superior outcomes to either treatment alone ^[2].

Biocompatibility

Because PDRN nucleotides are structurally identical to human nucleotides — adenine, guanine, cytosine, and thymine linked to deoxyribose — they are recognized as natural metabolites by human cells. Salmon DNA shares over 95% sequence homology with human DNA, and at the nucleotide level the components are chemically indistinguishable. This is why PDRN products consistently demonstrate excellent biocompatibility with minimal immunogenic potential ^[2][5].

Key Takeaways

Nucleotides are the fundamental units that compose all DNA, including the PDRN used in regenerative skincare and aesthetic medicine. When PDRN is applied to skin tissue, enzymatic degradation releases individual nucleotides and nucleosides that cells absorb and recycle through the salvage pathway, providing the metabolic raw materials for DNA replication and repair. This substrate-supply mechanism, combined with adenosine A2A receptor activation from the same degradation process, gives PDRN its uniquely comprehensive approach to tissue regeneration — simultaneously telling cells to regenerate and providing the molecular building blocks they need to do so.